当前位置:首页 > English > pregnancy and family > General Health > FDA Highlights ADHD Drug Warnings

FDA Highlights ADHD Drug Warnings

来源:www.webmd.com 作者:MirandaHitti 2007-2-22
336*280 ads

摘要: 21, 2007 -- The FDA today ordered all ADHD drug makers to print patient medication guides warning of possible heart and psychiatric risks associated with the drugs。Those possible risks are already noted in the warning labels of all drugs approved by the FDA to treat ADHD (attention deficit hyper......



Feb. 21, 2007 -- The FDA today ordered all ADHD drug makers to print patient medication guides warning of possible heart and psychiatric risks associated with the drugs.

Those possible risks are already noted in the warning labels of all drugs approved by the FDA to treat ADHD (attention deficit hyperactivity disorder).

The planned medication guides are "just written in language that is more understandable for patients and their families," the FDA's Tom Laughren, MD, told reporters in a news conference.

Laughren directs the division of psychiatric products at the FDA's Center for Drug Evaluation and Research.

The FDA's action isn't meant to scare patients or their families, Laughren says.

"We consider these drugs quite safe, very effective, and in no way are we trying to inhibit appropriate prescribing," Laughren says.

The guides are intended to give patients and their families "the information that they need" to weigh the drugs' risks and benefits, Laughren says.

Medication Guides

The FDA has drafted medication guides for each ADHD drug and will work with drug companies to finalize the guides over the next month or so, Laughren says.

Pharmacists will give the medication guides to patients or their parents or caregivers when ADHD prescriptions are filled.

The guides will note reports of sudden death in patients who have heart problems or heart defects, reports of strokestroke and heart attackheart attack in adults, and reports of increased blood pressure and heart rate.

It's not certain that ADHD drugs caused those problems, Laughren says.

The guides will also note the possibility of new or worsening psychiatric problems such as hearing voices, becoming suspicious for no reason, or becoming manic.

Those psychiatric problems are "quite rare," affecting about one in a thousand patients, Laughren says.

Talk to Your Doctor

Before taking ADHD drugs, patients should tell their doctor about any history of heart problems or psychiatric problems and get a thorough checkup, says the FDA.

Patients should also report any new symptoms -- including shortness of breath, chest pain, fainting, or other possible signs of heart trouble, as well as any mental problems -- while taking ADHD drugs.

Doctors should regularly monitor patients' heart rate and blood pressure during ADHD therapy, Laughren says.


SOURCES: News release, FDA. Tom Laughren, MD, director, Division of Psychiatric Products, Center for Drug Evaluation and Research, FDA.


医学百科App—医学基础知识学习工具


页:
返回顶部】【打印本文】【放入收藏夹】【收藏到新浪】【发布评论



察看关于《FDA Highlights ADHD Drug Warnings》的讨论


关闭

网站地图 | RSS订阅 | 图文 | 版权说明 | 友情链接
Copyright © 2008 39kf.com All rights reserved. 医源世界 版权所有
医源世界所刊载之内容一般仅用于教育目的。您从医源世界获取的信息不得直接用于诊断、治疗疾病或应对您的健康问题。如果您怀疑自己有健康问题,请直接咨询您的保健医生。医源世界、作者、编辑都将不负任何责任和义务。
本站内容来源于网络,转载仅为传播信息促进医药行业发展,如果我们的行为侵犯了您的权益,请及时与我们联系我们将在收到通知后妥善处理该部分内容
联系Email: